Huaxia Eye Hospital Group Co.,Ltd.

301267

CNE100005WL5

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
24.06 ^CNY	-1.92%		-5.61%	-25.02%

30/04	Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. from Xiamen Huaxia Juxin No. 1 Investment Partnership Enterprise (Limited Partnership) and Nanjing Xinke Dongzheng 01 Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 500 million.	CI
26/04	Huaxia Eye Hospital Group Co.,Ltd. Proposes Final Cash Dividend for 2023	CI

Huaxia Eye Hospital Group Co.,Ltd. has completed an IPO in the amount of CNY 3.0528 billion.

October 25, 2022 at 09:30 am IST

Huaxia Eye Hospital Group Co.,Ltd. has completed an IPO in the amount of CNY 3.0528 billion.

Security Name: A Shares
Security Type: Common Stock
Securities Offered: 60,000,000
PriceRange: CNY 50.88

Latest news about Huaxia Eye Hospital Group Co.,Ltd.

Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. from Xiamen Huaxia Juxin No. 1 Investment Partnership Enterprise (Limited Partnership) and Nanjing Xinke Dongzheng 01 Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 500 million.	30/04	CI
Huaxia Eye Hospital Group Co.,Ltd. Proposes Final Cash Dividend for 2023	27/04	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/04	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Tranche Update on Huaxia Eye Hospital Group Co.,Ltd.'s Equity Buyback Plan announced on January 9, 2024.	01/04	CI
Huaxia Eye Hospital Group Co.,Ltd. announces an Equity Buyback for CNY 250 million worth of its shares.	08/01	CI
Huaxia Eye Hospital Group Co.,Ltd. authorizes a Buyback Plan.	08/01	CI
Huaxia Eye Hospital Group Co.,Ltd.(SZSE:301267) added to Shenzhen Stock Exchange Component Index	12/12	CI
Huaxia Eye Hospital Group Co.,Ltd.(SZSE:301267) added to Shenzhen Stock Exchange Component A Share Index	12/12	CI
Huaxia Eye Hospital Chairman, Actual Controller Detained for Personal Reasons	08/12	MT
Certain A Shares of Huaxia Eye Hospital Group Co.,Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2023.	07/11	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
Huaxia Eye Hospital Group Co.,Ltd.(XSEC:301267) added to S&P Global BMI Index	18/23/18	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire an additional 33% stake in Hefei Shining Eye Hospital Co., Ltd from Anhui Zhongshi Ophthalmologists Group Management Partnership Enterprise (Limited Partnership), Hefei Aiweixi Eyewear Co., Ltd., Anhui Shining Hospital Management Co., Ltd. and Chen Linyi for CNY 70 million	21/23/21	CI
Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 11, 2023	05/23/05	CI
Huaxia Eye Hospital Group Co.,Ltd.(XSEC:301267) added to FTSE All-World Index	19/23/19	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	03/22/03	CI
Huaxia Eye Hospital Group Co.,Ltd. has completed an IPO in the amount of CNY 3.0528 billion.	25/22/25	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	13/22/13	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	13/22/13	CI

Chart Huaxia Eye Hospital Group Co.,Ltd.

Duration

Period

Chart Huaxia Eye Hospital Group Co.,Ltd.

More charts

Huaxia Eye Hospital Group Co Ltd is a China-based company mainly engaged in ophthalmic medical business. The Company's main business is to provide diagnosis and treatment services for ophthalmic diseases through ophthalmic medical institutions, including specialized medical services for cataract, refraction, fundus diseases, strabismus, amblyopia and pediatric ophthalmology, ocular surface diseases, glaucoma and others. The Company is also engaged in glasses and pharmacy retail business. The Company mainly conducts its business in the domestic market.

Sector

Healthcare Facilities & Services

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Huaxia Eye Hospital Group Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

24.06 CNY

Average target price

44.27 CNY

Spread / Average Target

+84.00%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Doctor's Office

	1st Jan change	Capi.
HUAXIA EYE HOSPITAL GROUP CO.,LTD.	-25.02%	277.32Cr
TOPCHOICE MEDICAL CO., INC.	-20.64%	267.93Cr
AGILON HEALTH, INC.	-51.47%	250.46Cr
EUROEYES INTERNATIONAL EYE CLINIC LIMITED	+0.38%	22Cr
AIRSCULPT TECHNOLOGIES, INC.	-53.14%	20Cr
MEDSCI HEALTHCARE HOLDINGS LIMITED	-42.77%	19Cr
AESTHETIC CONNECT	-36.31%	11Cr

Doctor's Office